Skip to main content
. 2020 Jan 15;31(2):457–464. doi: 10.1111/jce.14345

Table 3.

Predictors for a clinical recurrence after catheter ablation of AF

Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Paroxysmal AF (n = 387)
Age, y 0.989 (0.959‐1.021) .499 0.970 (0.935‐1.008) .117
Male sex 0.470 (0.233‐0.948) .035* 0.537 (0.172‐1.677) .284
BSA, m2 0.131 (0.019‐0.913) .040* 0.402 (0.015‐10.490) .584
BMI, kg/m2 0.940 (0.836‐1.056) .295
Heart failure 0.722 (0.211‐2.475) .605
Hypertension 1.294 (0.646‐2.593) .467
Diabetes mellitus 0.696 (0.236‐2.057) .513
Stroke or TIA 2.106 (0.929‐4.775) .075
Vascular disease 1.298 (0.510‐3.300) .584
LA diameter, mm 0.958 (0.899‐1.021) .187
LAVI, mL/m2 1.003 (0.975‐1.032) .820
LV ejection fraction (%) 1.014 (0.970‐1.060) .544
E/Em 0.939 (0.845‐1.043) .238
LA voltage, mV 0.386 (0.173‐0.862) .020* 0.455 (0.191‐1.086) .076
AF duration, y 0.923 (0.815‐1.046) .208 0.983 (0.870‐1.110) .781
Persistent AF (n = 618)
Age, y 0.996 (0.981‐1.011) .588 0.990 (0.971‐1.010) .336
Male sex 1.063 (0.721‐1.569) .757 1.047 (0.626‐1.752) .860
BSA, m2 1.364 (0.569‐3.267) .486
BMI, kg/m2 1.008 (0.961‐1.058) .737
Heart failure 0.519 (0.325‐0.829) .006* 0.429 (0.230‐0.800) .008*
Hypertension 1.029 (0.744‐1.423) .863
Diabetes mellitus 0.729 (0.469‐1.133) .160
Stroke or TIA 0.788 (0.497‐1.250) .312
Vascular disease 1.034 (0.658‐1.625) .886
LA diameter, mm 1.042 (1.012‐1.073) .005* 1.058 (1.015‐1.102) .007*
LAVI, mL/m2 1.008 (0.995‐1.021) .234
LV ejection fraction (%) 1.009 (0.991‐1.029) .322
E/Em 0.976 (0.939‐1.014) .207
LA voltage, mV 0.331 (0.213‐0.514) <.001* 0.365 (0.227‐0.586) <.001*
AF duration, y 1.065 (1.033‐1.099) <.001* 1.064 (1.025‐1.104) .001*

Abbreviations: AF, atrial fibrillation; BMI, body mass index; BSA, body surface area; CI, confidence interval; E/Em, early mitral inflow velocity over the early diastolic mitral annular velocity; HR, hazard ratio; LA, left atrium; LAVI, left atrial volume index; LV, left ventricle; TIA, transient ischemic attack.

*

P < .05.